The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation

Summary

Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work .

Conditions

• COPD Exacerbation Acute

Interventions

OTHER

CONTROL

Pursed Lips breathing exercise, Active Respiratory Techniques Cycle, Postural Drainage, Mobilization, Calisthenic Exercises, and Patient Education. Relaxation positions and energy conservation techniques were taught in Patient Education

DEVICE

PEP DEVICE

Pursed Lips breathing exercise, Active Respiratory Techniques Cycle, Postural Drainage, Mobilization, Calisthenic Exercises, and Patient Education. Relaxation positions and energy conservation techniques were taught in Patient Education PEP training was applied using the Acapella device. In addition, participants were subjected to two sessions of 10 minutes each with the Acapella device. In the study, the Acapella device, capable of sustaining expiratory flow of at least 15 L/min for 3 seconds, was activated by taking a deep breath, holding the breath for 2-3 seconds, and then exhaling into the device.

DEVICE

HFCWO DEVICE

Patients were provided with conventional exercises including Pursed Lips breathing exercise, Active Respiratory Techniques Cycle, Postural Drainage, Mobilization, Calisthenic Exercises, and Patient Education. Relaxation positions and energy conservation techniques were taught in Patient Education In addition, participants will receive High-Frequency Chest Wall Oscillation (HFCWO) therapy twice a day for 10 minutes each. HFCWO training was applıed using the WEST device

Sponsors & Collaborators

• Gulhane Training and Research Hospital

  collaborator OTHER_GOV

• Saglik Bilimleri Universitesi

  lead OTHER

Principal Investigators

• ZUHAL KUNDURACILAR, PROF. DR. · SAGLIK BILIMLERI UNI

• GAMZE KOYUTURK, PT, PHD (C) · SAGLIK BILIMLERI UNI

• AYSUNA DINCER, DOCTOR · SAGLIK BILIMLERI UNI

• MEHMET YUKSEKKAYA, ASIST PROF · ANKARA UNI

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-05-01

Primary Completion

2024-06-10

Completion

2024-06-17

Countries

• Turkey (Türkiye)

Study Locations